Rona Therapeutics announced it has granted Roche an exclusive worldwide license for Rona's investigational RNAi candidate ...
In preclinical studies, ISM9546 exhibited sub-nanomolar VAV1 degradation potency across multiple cell-based assays. Oral ...
Exclusive agreement grants Visara worldwide rights outside Greater China to develop HT006.2.2 for neurotrophic keratitis, ...
Waters Corporation announced that it has launched Waters AI Link, a software capability that brings Anthropic's Model Context ...
Shanghai Ark Biopharmaceutical Secures US FDA IND Clearance for Phase II Trial of Long-Acting Influenza Prevention Drug ...
South Korea’s GCCL and LabConnect Partner to Strengthen Global Clinical Trial Operations Across APAC and North America ...
BioAgilytix company, announced the opening of a new Australian laboratory in Sydney, expanding its national footprint to four ...
SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) announce a collaboration to advance new prostate ...
Suvoda, a global clinical trial technology company, announced that Sofia, its AI assistant on the Suvoda Platform, is ready ...
CellCarta Partners with Waters Corporation to Advance Companion Diagnostics and Next-Generation Flow Cytometry ...
Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics' Syracuse facility in New York.
Five of the twelve Presidential Symposium late-breakers in Madrid trace back to molecules discovered in China. Here is what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results